Y-shaped trivalent aptamer for targeted visualization and tracking of reprogrammed astrocytes
Source abstract
Abstract
Despite extensive research into the diverse transformations and functions of astrocytes, conventional fluorescence immunohistochemistry for their distinct identification remains challenging and time-consuming, primarily due to the lack of cell surface binders specific to these glial cells. To address this limitation, we developed a specific and straightforward imaging strategy for primary astrocytes using cell surface-targeting aptamers. We identified a novel anti-astrocyte DNA aptamer (designated Ast17-30) through a 17-round cell-SELEX process incorporating magnetic-activated cell sorting, designed to bypass the technical hurdles of SELEX when applied to short-lived cells. To enhance binding affinity, we further engineered this aptamer into a Y-shaped trimer (Tri-ΔAst17-30), enabling clear discrimination between astrocytes and neurons. Consequently, the engineered trivalent aptamer facilitated rapid astrocyte-specific endocytosis within minutes due to its increased binding avidity. This capability enabled longitudinal monitoring of astrocyte conversion into induced neural precursor cells, observing moderate pro-inflammatory gene expression in their transcriptomic profiles. Furthermore, Tri-ΔAst17-30 bound strongly to astrocytic glioblastoma cells (U87MG), with minimal binding to glial glioblastoma cells (C6), confirming specificity for astrocytic tumor cells. Given the current absence of reliable live-astrocyte-specific imaging techniques, we propose that this trivalent anti-astrocyte DNA aptamer has potential for investigating developmental pathways and targeted therapy of these crucial glial cells.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advanced biosensing and bioanalysis techniques · CRISPR and Genetic Engineering · Pluripotent Stem Cells Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (55)
Show source-provided references
1. Heterogeneity in astrocyte morphology and physiology10.1016/j.brainresrev.2009.12.001 ↗
2. Reactive astrocytes: production, function, and therapeutic potential10.1016/j.immuni.2017.06.006 ↗
3. The emerging nature of astrocyte diversity10.1146/annurev-neuro-070918-050443 ↗
4. Transdifferentiation: a new promise for neurodegenerative diseases10.1038/s41419-018-0891-4 ↗
5. Mechanisms of disease: astrocytes in neurodegenerative disease10.1038/ncpneuro0355 ↗
6. Astrocytes: emerging therapeutic targets in neurological disorders10.1016/j.molmed.2019.04.010 ↗
7. Purification of rat and mouse astrocytes by immunopanning10.1101/pdb.err080101 ↗
8. Improved tools to study astrocytes10.1038/s41583-020-0264-8 ↗
9. Visualization of S100B-positive neurons and glia in the central nervous system of EGFP transgenic mice10.1002/cne.10552 ↗
10. GFAP promoter-controlled EGFP-expressing transgenic mice: a tool to visualize astrocytes and astrogliosis in living brain tissue10.1002/1098-1136(20010101)33:1<72::AID-GLIA1007>3.0.CO;2-A ↗
11. Variations in promoter activity reveal a differential expression and physiology of glutamate transporters by glia in the developing and mature CNS10.1523/JNEUROSCI.0790-07.2007 ↗
12. Generation and characterization of brain lipid-binding protein promoter-based transgenic mouse models for the study of radial glia10.1002/glia.20274 ↗
13. Isolation and characterization of living primary astroglial cells using the new GLAST-specific monoclonal antibody ACSA-110.1002/glia.22322 ↗
14. Anti-ACSA-2 defines a novel monoclonal antibody for prospective isolation of living neonatal and adult astrocytes10.1002/glia.23140 ↗
15. Localization of neuronal and glial glutamate transporters10.1016/0896-6273(94)90038-8 ↗
16. Development of DNA aptamers using Cell-SELEX10.1038/nprot.2010.66 ↗
17. Recent developments in cell-SELEX technology for aptamer selection10.1016/j.bbagen.2018.07.029 ↗
18. Recent progress in aptamer discoveries and modifications for therapeutic applications10.1021/acsami.0c05750 ↗
19. Aptamers as therapeutics10.1038/nrd3141 ↗
20. Aptamer-protein interactions: from regulation to biomolecular detection10.1021/acs.chemrev.3c00377 ↗
21. In vivo direct reprogramming of reactive glial cells into functional neurons after brain injury and in an Alzheimer'S disease model10.1016/j.stem.2013.12.001 ↗
22. Direct conversion of mouse astrocytes into neural progenitor cells and specific lineages of neurons10.1186/s40035-018-0132-x ↗
23. Direct conversion of astrocytes into neuronal cells by drug cocktail10.1038/cr.2015.120 ↗
24. Evolution of multivalent supramolecular assemblies of aptamers with target-defined spatial organization10.1038/s41565-025-01939-8 ↗
25. pH-responsive size-tunable self-assembled DNA dendrimers10.1002/anie.201205862 ↗
26. Generation of dopamine neurons from rodent fibroblasts through the expandable neural precursor cell stage10.1074/jbc.M114.629808 ↗
27. Astrocytes: glutamate producers for neurons10.1002/(SICI)1097-4547(19990815)57:4<417::AID-JNR1>3.0.CO;2-N ↗
28. Beyond the role of glutamate as a neurotransmitter10.1038/nrn916 ↗
29. Glutamate-dependent neuroglial calcium signaling differs between young and adult brain10.1126/science.1226740 ↗
30. Radial glial cells: are they really glia?10.1016/S0896-6273(01)00437-8 ↗
31. A controllable aptamer-based self-assembled DNA dendrimer for high affinity targeting, bioimaging and drug delivery
32. The appropriate marker for astrocytes: comparing the distribution and expression of three astrocytic markers in different mouse cerebral regions
33. SOX9 is an astrocyte-specific nuclear marker in the adult brain outside the neurogenic regions10.1523/JNEUROSCI.3199-16.2017 ↗
34. Astrocyte reactivity after brain injury-the role of galectins 1 and 310.1002/glia.22898 ↗
35. Extensive transcriptional and chromatin changes underlie astrocyte maturation in vivo and in culture10.1038/s41467-021-24624-5 ↗
36. Acyl-CoA synthetase 6 is required for brain docosahexaenoic acid retention and neuroprotection during aging10.1172/jci.insight.144351 ↗
37. Neuronal activity induces glutathione metabolism gene expression in astrocytes10.1002/glia.23455 ↗
38. Conserved properties of dentate gyrus neurogenesis across postnatal development revealed by single-cell RNA sequencing10.1038/s41593-017-0056-2 ↗
39. A single factor elicits multilineage reprogramming of astrocytes in the adult mouse striatum
40. Hedgehog: a key signaling in the development of the oligodendrocyte lineage10.3390/jdb4030028 ↗
41. A single-cell RNA sequencing study reveals cellular and molecular dynamics of the hippocampal neurogenic niche10.1016/j.celrep.2017.11.050 ↗
42. Transcription factor-based fate specification and forward programming for neural regeneration, Front10.3389/fncel.2020.00121 ↗
43. Olig1 expression pattern in neural cells during rat spinal cord development
44. Developmental impact of glutamate transporter overexpression on dopaminergic neuron activity and stereotypic behavior10.1038/s41380-021-01424-3 ↗
45. Cancer-associated fibroblast compositions change with breast cancer progression linking the ratio of S100A4 and PDPN CAFs to clinical outcome10.1038/s43018-020-0082-y ↗
46. Single-cell RNA sequencing of microglia throughout the mouse lifespan and in the injured brain reveals complex cell-state changes10.1016/j.immuni.2018.11.004 ↗
47. Inflammatory mediators alter the astrocyte transcriptome and calcium signaling elicited by multiple G-protein-coupled receptors10.1523/JNEUROSCI.1256-12.2012 ↗
48. Co-stimulation with IL-1β and TNF-α induces an inflammatory reactive astrocyte phenotype with neurosupportive characteristics in a human pluripotent stem cell model system10.1038/s41598-019-53414-9 ↗
49. Evaluating cell reprogramming, differentiation and conversion technologies in neuroscience10.1038/nrn.2016.46 ↗
50. Optogenetic calcium modulation in astrocytes enhances post-stroke recovery in chronic capsular infarct10.1126/sciadv.adn7577 ↗
51. Uncovering astrocyte morphological dynamics using optical diffraction tomography and shape-based trajectory inference10.1002/adhm.202402960 ↗
52. LPS and IL-1 differentially activate mouse and human astrocytes: role of CD1410.1002/glia.22657 ↗
53. Multifaceted role of CD14 in innate immunity and tissue homeostasis10.1016/j.cytogfr.2023.08.008 ↗
54. A distinct astrocyte subtype in the aging mouse brain characterized by impaired protein homeostasis10.1038/s43587-022-00257-1 ↗
55. Droplet-based forward genetic screening of astrocyte-microglia cross-talk10.1126/science.abq4822 ↗